🇺🇸 FDA

Drug profile · INN

florbetaben f-18

NEURACEQ

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

florbetaben f-18 (NEURACEQ) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN florbetaben f-18
Brand NEURACEQ
Route INTRAVENOUS
Formulation SOLUTION

Frequently asked questions

What is florbetaben f-18?

florbetaben f-18 (NEURACEQ) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for florbetaben f-18?

NEURACEQ is a marketed brand name for florbetaben f-18. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of florbetaben f-18?

florbetaben f-18 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.